Clinical and prognostic features of indolent non-follicular lymphoma:: A retrospective study on 425 patients performed by Italian lymphoma intergroup

被引：0

作者：

Vitolo, U ^{[1
]}

Baldini, L ^{[1
]}

Federico, M ^{[1
]}

Luminari, S ^{[1
]}

Stelitano, C ^{[1
]}

Colombi, M ^{[1
]}

Capalbo, S ^{[1
]}

Angrilli, M ^{[1
]}

Pulsoni, A ^{[1
]}

Scalabrini, DR ^{[1
]}

Villivà, N ^{[1
]}

Zinzani, PL ^{[1
]}

Cortellazzo, S ^{[1
]}

Rigacci, L ^{[1
]}

Orsucci, L ^{[1
]}

Ambrosetti, A ^{[1
]}

Rossi, G ^{[1
]}

Brugiatelli, M ^{[1
]}

机构：

[1] ASO S Giovanni Battista, UOA Ematol 2, Turin, Italy

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4643

引用

页码：277B / 277B

页数：1

共 50 条

[1] Infectious disease associations in indolent lymphoma (follicular, FL and non-follicular, nFL): Developing a lymphoma prevention strategy
Portlock, CS
Noy, A
Hamlin, P
Qin, J
Rosenzweig, L
Corcoran, S
Chey, W
Papanicolaou, G
Markowitz, A
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 607S - 607S
[2] Consolidated and innovative approaches in lymphoma. Indolent non-follicular lymphomas
Salar, Antonio
Arcaini, Luca
Lopez-Guillermo, Armando
DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 59 - 67
[3] A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma
Luminari, Stefano
Goldaniga, Maria
Cesaretti, Marina
Orsucci, Lorella
Tucci, Alessandra
Pulsoni, Alessandro
Salvi, Flavia
Arcaini, Luca
Carella, Angelo Michele
Tedeschi, Alessandra
Pinto, Antonello
Stelitano, Caterina
Baldini, Luca
LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 880 - 887
[4] Causes of Death in Non-Follicular Indolent B-Cell Lymphoma in the Rituximab Era
Tun, Aung M.
Mwangi, Raphael
Link, Brian K.
Feldman, Andrew L.
Maurer, Matthew J.
Witzig, Thomas E.
Thompson, Carrie A.
Novak, Anne J.
Villasboas, Jose C.
Farooq, Umar
Syrbu, Sergei
Cerhan, James R.
Habermann, Thomas M.
BLOOD, 2020, 136
[5] Infectious disease associations in advanced stage, indolent lymphoma (Follicular, FL and non-follicular, nFL): Developing a lymphoma prevention strategy.
Portlock, Carol S.
Hamlin, Paul A.
Noy, Ariela
Palomba, Maria Lia
Rosenzweig, Lisa
Walker, Darren
Corcoran, Stacie
Chey, William D.
Gaydos, Charlotte A.
Schwartz, Ira
Papanicolaou, Genovefa
Markowitz, Arnold
BLOOD, 2006, 108 (11) : 686A - 686A
[6] Clinical features and prognostic factors in 49 patients with follicular lymphoma at a single center: A retrospective analysis
Hao Wu
Hui-Cong Sun
Gui-Fang Ouyang
World Journal of Clinical Cases, 2023, (14) : 3176 - 3186
[7] Clinical features and prognostic factors in 49 patients with follicular lymphoma at a single center: A retrospective analysis
Wu, Hao
Sun, Hui-Cong
Ouyang, Gui-Fang
WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (14) : 3176 - 3186
[8] NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients
Arcaini, Luca
Luminari, Stefano
Cesaretti, Marina
Gaidano, Gianluca
Rattotti, Sara
Merli, Michele
Cabras, Maria Giuseppina
Spina, Michele
Baldini, Luca
Tedeschi, Alessandra
Orsucci, Lorella
da Silva, Maria Comes
Marcheselli, Luigi
Marcia, Torresan Delamein
Federico, Massimo
BLOOD, 2013, 122 (21)
[9] Fludarabine-Mitoxantrone Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients
Zinzani, Pier Luigi
Pellegrini, Cinzia
Broccoli, Alessandro
Gandolfi, Letizia
Stefoni, Vittorio
Casadei, Beatrice
Maglie, Roberto
Argnani, Lisa
Pileri, Stefano
HEMATOLOGICAL ONCOLOGY, 2015, 33 (03) : 141 - 146
[10] Clinical and biological prognostic factors in follicular lymphoma patients
Jona, Adam
Kenyeres, Anna
Barna, Sandor
Illes, Arpad
Simon, Zsofia
PLOS ONE, 2022, 17 (08):

← 1 2 3 4 5 →